Charles River Laboratories International Inc. (NYSE: CRL)

https://www.criver.com

Charles River Laboratories based in Wilmington, Massachusetts, partners with global pharmaceutical and biotechnology companies, government agencies and leading academic institutions to advance the drug discovery and development process, bringing drugs to market faster and more efficiently. Charles River's 8,000 employees serve clients worldwide. *

	Start	1949-01-01 established
	Group	Charles River (Group)
	Industry	drug development services
	Person	Foster, James C. (Charles River 200708 President + CEO)

	Region	Wilmington, MA
	Country	United States (USA)
	City	n. a. Wilmington, MA
		Address record changed: 2020-12-02

Basic data	Employees	H: 10,001 to 50,00 (2022-12-31)
	Currency	USD
	Annual sales	3,976,060,000 (revenue, total, consolidated (2022) 2022-12-25)
	Profit	492,608,000 (2022-12-31)
	Cash	233,912,000 (2022-12-31)

		* Document for »About Section«:

		Record changed: 2026-01-13

Picture EBD Group BIO-Europe Spring 2026 Lisbon to 20 Mar 650x200px

More documents for Charles River (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com